Treace Medical Concepts, Inc. TMCI

Treace Medical Concepts, Inc. (NASDAQ:TMCI) announced five-year ALIGN3D results on September 17, adding longer-term evidence for the Lapiplasty bunion-correction procedure. The final analysis included 137 of 173 treated patients, or approximately 79% of the original group. Reported radiographic recurrence was 0.8% when defined as a hallux valgus angle greater than 20 degrees and 5.3% using […]

PONTE VEDRA, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle conditions, today announced the presentation of the results from three clinical studies at the American Orthopaedic Foot & Ankle Society (“AOFAS”) Annual Meeting in Seattle, Washington. The presentations include data on the milestone 5-year ALIGN3D® Lap

New product offerings extend bunion market leadership and accelerate penetration into new foot & ankle market adjacenciesPONTE VEDRA, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle conditions, today announced it will highlight multiple new product innovations and present clinical data at the American Orthopaedic

Moby summary of Treace Medical Concepts, Inc.'s Q2 2026 earnings call

Despite a 4% year-over-year revenue dip, Treace Medical Concepts Inc (TMCI) narrows its adjusted EBITDA loss and raises full-year guidance on strong adoption of new bunion systems.

Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +20.00% and +3.42%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

PONTE VEDRA, Fla., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related deformities, today reported financial results for the second quarter ended June 30, 2026. Recent Highlights Generated revenue of $45.4 million in the second quarter 2026 compared to $47.4 million in the same period in 2025. Reported second quarter 2026 net loss of

PONTE VEDRA, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the second quarter 2026 before the start of trading on Friday, August 7, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET. Inves

New portfolio addition to drive further penetration into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer basePONTE VEDRA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the

NEW YORK, NY / ACCESS Newswire / June 16, 2026 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Virtual Investor Conference taking place Wednesday and Thursday, ...

Over the last 7 days, the United States market has dropped 4.1%, though it has risen by 21% over the past year with earnings forecast to grow by 18% annually. For investors willing to look beyond established companies, penny stocks can present intriguing opportunities, despite their somewhat outdated label. These stocks often represent smaller or newer companies that may offer surprising value and potential for growth when backed by solid financial foundations.